Literature DB >> 21219575

Distinct inflammatory signals have physiologically divergent effects on epigenetic regulation of Foxp3 expression and Treg function.

G Lal1, N Yin, J Xu, M Lin, S Schroppel, Y Ding, I Marie, D E Levy, J S Bromberg.   

Abstract

Foxp3 expression in regulatory T cells (Treg) is required for their development and suppressive function. How different inflammatory signals affect Foxp3 chromatin structure, expression and Tregs plasticity are not completely known. In the present study, the Toll-like receptor 2 (TLR2) ligand peptidoglycan inhibited Foxp3 expression in both natural Treg (nTreg) and TGFβ-driven adaptive Treg (aTreg). Inhibition was independent of paracrine Th1, Th2 and Th17 cytokines. PGN-induced T cell-intrinsic TLR2-Myd88-dependent IFR1 expression and induced IRF1 bound to IRF1 response elements (IRF-E) in the Foxp3 promoter and intronic enhancers, and negatively regulated Foxp3 expression. Inflammatory IL-6 and TLR2 signals induced divergent chromatin changes at the Foxp3 locus and regulated Treg suppressor function, and in an islet transplant model resulted in differences in their ability to prolong graft survival. These findings are important for understanding how different inflammatory signals can affect the transplantation tolerance and immunity. ©2011 The Authors Journal compilation©2011 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21219575      PMCID: PMC3079560          DOI: 10.1111/j.1600-6143.2010.03389.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  42 in total

1.  Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells.

Authors:  Chandrashekhar Pasare; Ruslan Medzhitov
Journal:  Science       Date:  2003-01-16       Impact factor: 47.728

2.  Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling.

Authors:  Alexandra Zanin-Zhorov; Liora Cahalon; Guy Tal; Raanan Margalit; Ofer Lider; Irun R Cohen
Journal:  J Clin Invest       Date:  2006-06-08       Impact factor: 14.808

3.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

4.  Toll-dependent selection of microbial antigens for presentation by dendritic cells.

Authors:  J Magarian Blander; Ruslan Medzhitov
Journal:  Nature       Date:  2006-02-19       Impact factor: 49.962

5.  Toll-like receptor 2 controls expansion and function of regulatory T cells.

Authors:  Roger P M Sutmuller; Martijn H M G M den Brok; Matthijs Kramer; Erik J Bennink; Liza W J Toonen; Bart-Jan Kullberg; Leo A Joosten; Shizuo Akira; Mihai G Netea; Gosse J Adema
Journal:  J Clin Invest       Date:  2006-01-19       Impact factor: 14.808

6.  IFN-gamma and IL-4 differently regulate inducible NO synthase gene expression through IRF-1 modulation.

Authors:  E M Coccia; E Stellacci; G Marziali; G Weiss; A Battistini
Journal:  Int Immunol       Date:  2000-07       Impact factor: 4.823

7.  Interplay between repressing and activating domains defines the transcriptional activity of IRF-1.

Authors:  S Kirchhoff; A Oumard; M Nourbakhsh; B Z Levi; H Hauser
Journal:  Eur J Biochem       Date:  2000-12

8.  TNF downmodulates the function of human CD4+CD25hi T-regulatory cells.

Authors:  Xavier Valencia; Geoffrey Stephens; Raphaela Goldbach-Mansky; Mildred Wilson; Ethan M Shevach; Peter E Lipsky
Journal:  Blood       Date:  2006-03-14       Impact factor: 22.113

9.  Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells.

Authors:  Haiying Liu; Mousa Komai-Koma; Damo Xu; Foo Y Liew
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-21       Impact factor: 11.205

10.  TLR2 is expressed on activated T cells as a costimulatory receptor.

Authors:  Mousa Komai-Koma; Louise Jones; Graham S Ogg; Damo Xu; Foo Y Liew
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-23       Impact factor: 11.205

View more
  25 in total

Review 1.  A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome.

Authors:  Gerwyn Morris; Michael Maes
Journal:  Metab Brain Dis       Date:  2012-06-21       Impact factor: 3.584

2.  mTOR Complex 1 Signaling Regulates the Generation and Function of Central and Effector Foxp3+ Regulatory T Cells.

Authors:  Im-Hong Sun; Min-Hee Oh; Liang Zhao; Chirag H Patel; Matthew L Arwood; Wei Xu; Ada J Tam; Richard L Blosser; Jiayu Wen; Jonathan D Powell
Journal:  J Immunol       Date:  2018-06-08       Impact factor: 5.422

3.  PLG scaffold delivered antigen-specific regulatory T cells induce systemic tolerance in autoimmune diabetes.

Authors:  John G Graham; Xiaomin Zhang; Ashley Goodman; Kathryn Pothoven; Josetta Houlihan; Shusen Wang; R Michael Gower; Xunrong Luo; Lonnie D Shea
Journal:  Tissue Eng Part A       Date:  2013-04-03       Impact factor: 3.845

4.  Immunomodulation of host-protective immune response by regulating Foxp3 expression and Treg function in Leishmania-infected BALB/c mice: critical role of IRF1.

Authors:  Bidisha Paul Chowdhury; Shibali Das; Saikat Majumder; Kuntal Halder; Sweta Ghosh; Satabdi Biswas; Syamdas Bandyopadhyay; Subrata Majumdar
Journal:  Pathog Dis       Date:  2015-08-21       Impact factor: 3.166

Review 5.  The dual role of the X-linked FoxP3 gene in human cancers.

Authors:  Margaret Redpath; Bin Xu; Leon C van Kempen; Alan Spatz
Journal:  Mol Oncol       Date:  2011-03-30       Impact factor: 6.603

6.  FOXJ2 expression in rat spinal cord after injury and its role in inflammation.

Authors:  Xiang Chen; Xingjian Cao; Guohua Tao; Zhaoming Cao; Shuo Wang; Feng Zhou; Wei Xie; Peng Zhao; Zheping Zhang; Zhiming Cui
Journal:  J Mol Neurosci       Date:  2012-01-13       Impact factor: 3.444

Review 7.  Nature and nurture in Foxp3(+) regulatory T cell development, stability, and function.

Authors:  Terrence L Geiger; Sharyn Tauro
Journal:  Hum Immunol       Date:  2011-12-27       Impact factor: 2.850

8.  Engagement of Toll-like receptor 2 enhances interleukin (IL)-17(+) autoreactive T cell responses via p38 mitogen-activated protein kinase signalling in dendritic cells.

Authors:  R Wei; L Dong; Q Xiao; D Sun; X Li; H Nian
Journal:  Clin Exp Immunol       Date:  2014-11       Impact factor: 4.330

Review 9.  Impact of Immune-Modulatory Drugs on Regulatory T Cell.

Authors:  Akiko Furukawa; Steven A Wisel; Qizhi Tang
Journal:  Transplantation       Date:  2016-11       Impact factor: 4.939

10.  The plasticity and stability of regulatory T cells.

Authors:  Shimon Sakaguchi; Dario A A Vignali; Alexander Y Rudensky; Rachel E Niec; Herman Waldmann
Journal:  Nat Rev Immunol       Date:  2013-05-17       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.